Recurrent Glioblastoma Multiforme(GBM)
6 clinical trials · Condition
◉ Watch Recurrent Glioblastoma Multiforme(GBM)
| Record | Firm | Date |
|---|---|---|
| Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma (NCT04782609) | Samus Therapeutics, Inc. | 2021-12-27 |
| A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme (NCT05053880) | Accendatech USA Inc. | 2021-09-22 |
| Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) (NCT00290771) | Novartis | 2006-02-01 |
Track Recurrent Glioblastoma Multiforme(GBM) automatically
Every clearance here is in the API, with alerts when new ones post.